| 1 |
30250148 | Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis. | 2018 Dec |
1 |
| 2 |
27631194 | Mapping SLCO1B1 Genetic Variation for Global Precision Medicine in Understudied Regions in Africa: A Focus on Zulu and Cape Admixed Populations. | 2016 Sep |
1 |
| 3 |
24971633 | Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions. | 2014 Oct |
1 |
| 4 |
23652407 | OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. | 2013 Jul |
7 |
| 5 |
21386754 | Cerivastatin, genetic variants, and the risk of rhabdomyolysis. | 2011 May |
1 |
| 6 |
15194707 | Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil. | 2004 Oct |
8 |
| 7 |
15365880 | A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin. | 2004 |
2 |